D
Cardiff Oncology, Inc. CRDF
$4.00 $0.051.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 684.00K 689.00K 665.00K 610.00K 488.00K
Total Other Revenue -- -- -- -- --
Total Revenue 684.00K 689.00K 665.00K 610.00K 488.00K
Cost of Revenue 36.85M 34.90M 33.29M 31.81M 32.86M
Gross Profit -36.17M -34.22M -32.62M -31.20M -32.37M
SG&A Expenses 12.48M 12.20M 12.01M 13.09M 13.04M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 49.34M 47.10M 45.30M 44.90M 45.90M
Operating Income -48.65M -46.41M -44.63M -44.29M -45.41M
Income Before Tax -45.43M -42.98M -40.86M -40.23M -41.44M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -45.43 -42.98 -40.86 -40.23 -41.44
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -45.43M -42.98M -40.86M -40.23M -41.44M
EBIT -48.65M -46.41M -44.63M -44.29M -45.41M
EBITDA -48.25M -46.00M -44.21M -43.88M -45.01M
EPS Basic -0.96 -0.95 -0.91 -0.90 -0.93
Normalized Basic EPS -0.60 -0.59 -0.57 -0.56 -0.58
EPS Diluted -0.96 -0.95 -0.91 -0.90 -0.93
Normalized Diluted EPS -0.60 -0.59 -0.57 -0.56 -0.58
Average Basic Shares Outstanding 190.59M 181.05M 178.86M 178.71M 178.71M
Average Diluted Shares Outstanding 190.59M 181.05M 178.86M 178.71M 178.71M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings